Iperionx Limited American Stock Alpha and Beta Analysis

IPX Stock  USD 36.95  0.02  0.05%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as IperionX Limited American. It also helps investors analyze the systematic and unsystematic risks associated with investing in IperionX Limited over a specified time horizon. Remember, high IperionX Limited's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to IperionX Limited's market risk premium analysis include:
Beta
2.48
Alpha
(0.47)
Risk
3.91
Sharpe Ratio
(0.1)
Expected Return
(0.37)
Please note that although IperionX Limited alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, IperionX Limited did 0.47  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of IperionX Limited American stock's relative risk over its benchmark. IperionX Limited American has a beta of 2.48  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, IperionX Limited will likely underperform. At this time, IperionX Limited's Book Value Per Share is fairly stable compared to the past year. Tangible Asset Value is likely to rise to about 2.2 M in 2025, whereas Net Current Asset Value is likely to drop slightly above 799.5 K in 2025.

Enterprise Value

913.16 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out IperionX Limited Backtesting, IperionX Limited Valuation, IperionX Limited Correlation, IperionX Limited Hype Analysis, IperionX Limited Volatility, IperionX Limited History and analyze IperionX Limited Performance.

IperionX Limited Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. IperionX Limited market risk premium is the additional return an investor will receive from holding IperionX Limited long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IperionX Limited. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate IperionX Limited's performance over market.
α-0.47   β2.48

IperionX Limited expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of IperionX Limited's Buy-and-hold return. Our buy-and-hold chart shows how IperionX Limited performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

IperionX Limited Market Price Analysis

Market price analysis indicators help investors to evaluate how IperionX Limited stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IperionX Limited shares will generate the highest return on investment. By understating and applying IperionX Limited stock market price indicators, traders can identify IperionX Limited position entry and exit signals to maximize returns.

IperionX Limited Return and Market Media

The median price of IperionX Limited for the period between Tue, Sep 30, 2025 and Mon, Dec 29, 2025 is 37.47 with a coefficient of variation of 22.14. The daily time series for the period is distributed with a sample standard deviation of 9.2, arithmetic mean of 41.57, and mean deviation of 8.37. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Australian Shares Flat Elders Posts Higher Fiscal Year 2025 Underlying Earnings, Revenue
11/17/2025
2
Will US Government Backing Resolve Doubts About IperionXs Titanium Technology
11/18/2025
3
IperionX Valuation in Focus After Short Seller Report and Company Response
11/19/2025
4
JPMorgan Ceases Substantial Holding in Iperionx Limited - TipRanks
11/24/2025
5
The 4 worst performing ASX 200 stocks to hold in November unmasked
12/01/2025
6
3 ASX Growth Stocks With High Insider Ownership And Up To 61 percent Revenue Growth
12/02/2025
7
Disposition of 1562753 shares by Tuchman Martin of IperionX Limited at 24.78 subject to Rule 16b-3
12/11/2025
8
NGT Launches Wellness Campaign with JOGUMANUnveils Four Special-Edition Products
12/19/2025
9
Is IperionX Using Navy Prototypes To Prove A Scalable Titanium Advantage
12/26/2025

About IperionX Limited Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including IperionX or other stocks. Alpha measures the amount that position in IperionX Limited American has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

IperionX Limited Upcoming Company Events

As portrayed in its financial statements, the presentation of IperionX Limited's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IperionX Limited's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of IperionX Limited's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of IperionX Limited. Please utilize our Beneish M Score to check the likelihood of IperionX Limited's management manipulating its earnings.
22nd of September 2023
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View

Build Portfolio with IperionX Limited

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for IperionX Stock Analysis

When running IperionX Limited's price analysis, check to measure IperionX Limited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IperionX Limited is operating at the current time. Most of IperionX Limited's value examination focuses on studying past and present price action to predict the probability of IperionX Limited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IperionX Limited's price. Additionally, you may evaluate how the addition of IperionX Limited to your portfolios can decrease your overall portfolio volatility.